Susceptibility of Pediatric Acute Lymphoblastic Leukemia to STAT3 Inhibition Depends on p53 Induction

Investigators demonstrated that pharmacological or genetic inhibition of signal transducer and activator of transcription 3 (STAT3) resulted in p53 induction and that CRISPR-mediated TP53 knockout substantially reverses susceptibility to STAT3 inhibition.